Bile acids: Chemistry, physiology, and pathophysiology

World Journal of Gastroenterology

Volumn 15, Issue 7, 2009, Pages 804-816

  Monte, Maria J ^a   Marin, Jose J G ^a   Antelo, Alvaro ^b   Vazquez Tato, Jose ^b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b University of Santiago de Compastela   (Spain)

Author keywords

Cholestasis; Cholesterol; Liver; Metabolism; Transport

Indexed keywords

BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME P450 7A1, MOUSE; STEROL; VITAMIN;

APOPTOSIS; ARTICLE; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CHEMICAL STRUCTURE; DIGESTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; GENETIC DISORDER; HUMAN; INTRAHEPATIC CHOLESTASIS; LIPID ABSORPTION; LIVER DISEASE; LIVER INJURY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREGNANCY OUTCOME; STEROIDOGENESIS; BILE; BIOSYNTHESIS; CHEMISTRY; CHOLESTASIS; FAT INTAKE; GENETICS; HOMEOSTASIS; INTESTINE ABSORPTION; LIVER; METABOLISM; PEROXISOME; PHYSIOLOGY; REVIEW; SECRETION; TRANSPORT AT THE CELLULAR LEVEL;

BILE; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CHOLESTASIS; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DIETARY FATS; HOMEOSTASIS; HUMANS; INTESTINAL ABSORPTION; LIVER; MODELS, MOLECULAR; PEROXISOMES; STEROLS; VITAMINS;

EID: 65649129982     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.804     Document Type: Article

References (143)

1. Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999; 159: 2647-2658
2. Babu P, Sangeetha NM, Maitra U. Supramolecular chemistry of bile acid derivatives: formation of gels. Macromol Symp 2006; 241: 60-67
3. Hofmann AF, Mysels KJ. Bile salts as biological surfactants. Colloids Surfaces 1988; 30: 145-173
4. Hofmann AF, Sjövall J, Kurz G, Radominska A, Schteingart CD, Tint GS, Vlahcevic ZR, Setchell KD. A proposed nomenclature for bile acids. J Lipid Res 1992; 33: 599-604
5. Warren DB, Chalmers DK, Hutchison K, Dang W, Pouton CW. Molecular dynamics simulations of spontaneous bile salt aggregation. Colloids Surfaces A 2006; 280: 182-193
6. Clouse SD. Brassinosteroids. In: Somerville C, Meyerowitz E, eds. The Arabidopsis Book. Rockville, MD: American Society of Plant Biologists, 2002: 1-23
7. Volkman JK. Sterols and other triterpenoids: source specificity and evolution of biosynthetic pathways. Org Geochem 2005; 36: 139-159
8. Connolly JD, Hill RA. Triterpenoids. Nat Prod Rep 2008; 25: 794-830
9. Haslewood GA. The biological significance of chemical differences in bile salts. Biol Rev Camb Philos Soc 1964; 39: 537-574
10. Haslewood GA. Bile salt evolution. J Lipid Res 1967; 8: 535-550
11. Kuroki S, Schteingart CD, Hagey LR, Cohen BI, Mosbach EH, Rossi SS, Hofmann AF, Matoba N, Une M, Hoshita T. Bile salts of the West Indian manatee, Trichechus manatus latirostris: novel bile alcohol sulfates and absence of bile acids. J Lipid Res 1988; 29: 509-522
12. Savage PB, Li C, Taotafa U, Ding B, Guan Q. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol Lett 2002; 217: 1-7
13. Savage PB. Cationic Steroid Antibiotics. Curr Med Chem 2002; 1: 293-304
14. Savage PB. Design, synthesis and characterization of cationic peptide and steroid antibiotics. Eur J Org Chem 2002; 759-768
15. Bandyopadhyaya AK, Sangeetha NM, Maitra U. Highly diastereoselective synthesis of the 1,1′-binaphthol unit on a bile acid template. J Org Chem 2000; 65: 8239-8244
16. Soto Tellini VH, Jover A, Galantini L, Pavel NV, Meijide F, Vázquez Tato J. New lamellar structure formed by an adamantyl derivative of cholic acid. J Phys Chem B 2006; 110: 13679-13681
17. Soto Tellini VH, Jover A, Meijide F, Vázquez Tato J, Galantini L, Pavel NV. Supramolecular structures generated by a p-tert-butylphenyl-amide derivative of cholic acid. From vesicles to molecular tubes. Adv Mater 2007; 19: 1752-1756
18. Nath S, Maitra U. A simple and general strategy for the design of fluorescent cation sensor beads. Org Lett 2006; 8: 3239-3242
19. Davis AP, Joos J-B. Steroids as organising elements in anion receptors. Coord Chem Rev 2003; 240: 143-156
20. Ghosh S, Choudhury AR, Guru Row TN, Maitra U. Selective and unusual fluoride ion complexation by a steroidal receptor using OH...F- and CH...F- interactions: a new motif for anion coordination? Org Lett 2005; 7: 1441-1444
21. Yoshii M, Yamamura M, Satake A, Kobuke Y. Supramolecular ion channels from a transmembrane bischolic acid derivative showing two discrete conductances. Org Biomol Chem 2004; 2: 2619-2623
22. Enhsen A, Kramer W, Wess G. Bile acids in drug discovery. Drug Discov Today 1998; 3: 409-418
23. Ropponen J, Tamminen J, Lahtinen M, Linnanto J, Rissanen K, Kolehmainen E. Synthesis, characterization, and thermal behavior of steroidal dendrons. Eur J Org Chem 2005; 73-84
24. Zhao Y. Facial amphiphiles in molecular recognition: From unusual aggregates to solvophobically driven foldamers. Curr Opin Colloid Interface Sci 2007; 12: 92-97
25. del Amo V, Siracusa L, Markidis T, Baragaña B, Bhattarai KM, Galobardes M, Naredo G, Pérez-Payán MN, Davis AP. Differentially-protected steroidal triamines; scaffolds with potential for medicinal, supramolecular, and combinatorial chemistry. Org Biomol Chem 2004; 2: 3320-3328
26. Alvarez Alcalde M, Jover A, Meijide F, Galantini L, Pavel NV, Antelo A, Vázquez Tato J. Synthesis and characterization of a new gemini surfactant derived from 3alpha,12alpha-dihydroxy-5beta-cholan-24-amine (steroid residue) and ethylenediamintetraacetic acid (spacer). Langmuir 2008; 24: 6060-6066
27. Nonappa, Maitra U. Unlocking the potential of bile acids in synthesis, supramolecular/materials chemistry and nanoscience. Org Biomol Chem 2008; 6: 657-669
28. Davis AP. Bile acid scaffolds in supramolecular chemistry: the interplay of design and synthesis. Molecules 2007; 12: 2106-2122
29. Hofmann AF. Bile Acids: The Good, the Bad, and the Ugly. News Physiol Sci 1999; 14: 24-29
30. Coello A, Meijide F, Núńez ER, Tato JV. Aggregation behavior of bile salts in aqueous solution. J Pharm Sci 1996; 85: 9-15
31. Coello A, Meijide F, Rodríguez Nuñez E, Vázquez Tato J. Aggregation behavior of sodium cholate in aqueous solution. J Phys Chem 1993; 97: 10186-10191
32. Armstrong MJ, Carey MC. The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities. J Lipid Res 1982; 23: 70-80
33. Jover A, Meijide F, Rodríguez Núñez E, Vázquez Tato J. Aggregation behavior of bile salts. Recent Res Dev Phys Chem 1999; 3: 323-335
34. Reis S, Moutinho CG, Matos C, de Castro B, Gameiro P, Lima JL. Noninvasive methods to determine the critical micelle concentration of some bile acid salts. Anal Biochem 2004; 334: 117-126
35. Carey MC. Measurement of the physical-chemical properties of bile salt solutions. In: Barbara L, Dowling RH, Hofmann AF, Roda E. Bile acids in Gastroenterology. Lancaster: MTP Press, 1983: 19-56
36. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989; 30: 719-730
37. Venneman NG, van Kammen M, Renooij W, Vanberge-Henegouwen GP, van Erpecum KJ. Effects of hydrophobic and hydrophilic bile salts on gallstone growth and dissolution in model biles. Biochim Biophys Acta 2005; 1686: 209-219
38. Natalini B, Sardella R, Camaioni E, Gioiello A, Pellicciari R. Correlation between CMC and chromatographic index: simple and effective evaluation of the hydrophobic/hydrophilic balance of bile acids. Anal Bioanal Chem 2007; 388: 1681-1688
39. Costantino G, Wolf C, Natalini B, Pellicciari R. Evaluation of hydrophobic/hydrophilic balance of bile acids by comparative molecular field analysis (CoMFA). Steroids 2000; 65: 483-489
40. Fini A, Fazio G, Roda A, Bellini AM, Mencini E, Guarneri M. Basic cholane derivatives. XI: Comparison between acid and basic derivatives. J Pharm Sci 1992; 81: 726-730
41. Bellini AM, Mencini E, Quaglio MP, Guarneri M, Fini A. Antimicrobial activity of basic cholane derivatives. Part IX. Arch Pharm (Weinheim) 1990; 323: 201-205
42. Erlinger S, Dhumeaux D, Berthelot P, Dumont M. Effect of inhibitors of sodium transport on bile formation in the rabbit. Am J Physiol 1970; 219: 416-422 43 Coleman R. Bile salts and biliary lipids. Biochem Soc Trans 1987; 15 Suppl: 68S-80S
43. Sanyal AJ, Hirsch JI, Moore EW. Premicellar taurocholate enhances calcium uptake from all regions of rat small intestine. Gastroenterology 1994; 106: 866-874
44. Koop I, Schindler M, Bosshammer A, Scheibner J, Stange E, Koop H. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids. Gut 1996; 39: 661-667
45. Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005; 29: 625-651
46. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362-1365
47. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999; 284: 1365-1368
48. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999; 3: 543-553
49. Maruyama T, Miyamoto Y, Nakamura T, Tamai Y, Okada H, Sugiyama E, Nakamura T, Itadani H, Tanaka K. Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 2002; 298: 714-719
50. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, Hinuma S, Fujisawa Y, Fujino M. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003; 278: 9435-9440
51. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J 2006; 25: 1419-1425
52. Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002; 23: 443-463
53. Eloranta JJ, Meier PJ, Kullak-Ublick GA. Coordinate transcriptional regulation of transport and metabolism. Methods Enzymol 2005; 400: 511-530
54. Geier A, Wagner M, Dietrich CG, Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta 2007; 1773: 283-308
55. Ma K, Saha PK, Chan L, Moore DD. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 2006; 116: 1102-1109
56. Axelson M, Ellis E, Mörk B, Garmark K, Abrahamsson A, Björkhem I, Ericzon BG, Einarsson C. Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid. Hepatology 2000; 31: 1305-1312
57. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003; 72: 137-174
58. Chiang JY. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 2004; 40: 539-551
59. Zhang M, Chiang JY. Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression. J Biol Chem 2001; 276: 41690-41699
60. Solaas K, Ulvestad A, Söreide O, Kase BF. Subcellular organization of bile acid amidation in human liver: a key issue in regulating the biosynthesis of bile salts. J Lipid Res 2000; 41: 1154-1162
61. Pellicoro A, van den Heuvel FA, Geuken M, Moshage H, Jansen PL, Faber KN. Human and rat bile acid-CoA: amino acid N-acyltransferase are liver-specific peroxisomal enzymes: implications for intracellular bile salt transport. Hepatology 2007; 45: 340-348
62. Axelson M, Sjövall J. Potential bile acid precursors in plasma - possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. J Steroid Biochem 1990; 36: 631-640
63. Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA 1999; 96: 7238-7243
64. Edwards PA, Kennedy MA, Mak PA. LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul Pharmacol 2002; 38: 249-256
65. Heuman DM, Hylemon PB, Vlahcevic ZR. Regulation of bile acid synthesis. III. Correlation between biliary bile salt hydrophobicity index and the activities of enzymes regulating cholesterol and bile acid synthesis in the rat. J Lipid Res 1989; 30: 1161-1171
66. Pandak WM, Vlahcevic ZR, Heuman DM, Redford KS, Chiang JY, Hylemon PB. Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 alpha-hydroxylase. Hepatology 1994; 19: 941-947
67. Lew JL, Zhao A, Yu J, Huang L, De Pedro N, Peláez F, Wright SD, Cui J. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. J Biol Chem 2004; 279: 8856-8861
68. Stroup D, Crestani M, Chiang JY. Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A. Am J Physiol 1997; 273: G508-G517
69. Yang Y, Zhang M, Eggertsen G, Chiang JY. On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha. Biochim Biophys Acta 2002; 1583: 63-73 71 Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6: 517-526
70. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000; 6: 507-515
71. Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, Goodwin B, Jones SA. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 2003; 17: 1581-1591
72. Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, Gonzalez FJ. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 2007; 48: 2664-2672
73. Lee YK, Schmidt DR, Cummins CL, Choi M, Peng L, Zhang Y, Goodwin B, Hammer RE, Mangelsdorf DJ, Kliewer SA. Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol 2008; 22: 1345-1356
74. Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001; 262: 257-265
75. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol 2003; 17: 386-394
76. Twisk J, Hoekman MF, Lehmann EM, Meijer P, Mager WH, Princen HM. Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription. Hepatology 1995; 21: 501-510 79 Li T, Kong X, Owsley E, Ellis E, Strom S, Chiang JY. Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. J Biol Chem 2006; 281: 28745-28754
77. Ness GC, Lopez D. Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone. Arch Biochem Biophys 1995; 323: 404-408
78. Sauter G, Weiss M, Hoermann R. Cholesterol 7 alpha-hydroxylase activity in hypothyroidism and hyperthyroidism in humans. Horm Metab Res 1997; 29: 176-179
79. Miao J, Fang S, Bae Y, Kemper JK. Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J Biol Chem 2006; 281: 14537-14546
80. Li T, Chiang JY. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. Am J Physiol Gastrointest Liver Physiol 2005; 288: G74-G84
81. Chiang JY, Miller WF, Lin GM. Regulation of cholesterol 7 alpha-hydroxylase in the liver. Purification of cholesterol 7 alpha-hydroxylase and the immunochemical evidence for the induction of cholesterol 7 alpha-hydroxylase by cholestyramine and circadian rhythm. J Biol Chem 1990; 265: 3889-3897
82. Inoue Y, Yu AM, Yim SH, Ma X, Krausz KW, Inoue J, Xiang CC, Brownstein MJ, Eggertsen G, Björkhem I, Gonzalez FJ. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha. J Lipid Res 2006; 47: 215-227
83. Lundåsen T, Gälman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 2006; 260: 530-536
84. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47: 241-259
85. Batta AK, Salen G, Arora R, Shefer S, Batta M, Person A. Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids. J Biol Chem 1990; 265: 10925-10928
86. McGarr SE, Ridlon JM, Hylemon PB. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J Clin Gastroenterol 2005; 39: 98-109
87. Martinez-Augustin O, Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J Gastroenterol 2008; 14: 5630-5640
88. Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 1998; 274: G157-G169
89. Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV, Ballatori N. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 2005; 280: 6960-6968
90. Hofmann AF. Bile acids. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA. The Liver: Biology and Pathobiology. New York: Raven Press, Ldt., 1988: 553-572
91. Hagenbuch B, Meier PJ. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest 1994; 93: 1326-1331
92. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 2001; 120: 525-533
93. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273: 10046-10050
94. Akita H, Suzuki H, Ito K, Kinoshita S, Sato N, Takikawa H, Sugiyama Y. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim Biophys Acta 2001; 1511: 7-16
95. Blazquez AG, Briz O, Serrano MA, Marin JJG. Role of human breast cancer resistance protein (BCRP/ABCG2) in the canalicular transport of bile acid derivatives. Acta Physiol 2007; 190: 103
96. El-Mir MY, Badia MD, Luengo N, Monte MJ, Marin JJ. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma. Clin Sci (Lond) 2001; 100: 499-508
97. Bove KE, Heubi JE, Balistreri WF, Setchell KD. Bile acid synthetic defects and liver disease: a comprehensive review. Pediatr Dev Pathol 2004; 7: 315-334
98. Stieger B, Zhang J, O'Neill B, Sjövall J, Meier PJ. Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters. Eur J Biochem 1997; 244: 39-44
99. Fischler B, Bodin K, Stjernman H, Olin M, Hansson M, Sjövall J, Björkhem I. Cholestatic liver disease in adults may be due to an inherited defect in bile acid biosynthesis. J Intern Med 2007; 262: 254-262
100. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 2002; 110: 109-117 104 Setchell KD, Schwarz M, O'Connell NC, Lund EG, Davis DL, Lathe R, Thompson HR, Weslie Tyson R, Sokol RJ, Russell DW. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 1998; 102: 1690-1703
101. Jacquemin E, Setchell KD, O'Connell NC, Estrada A, Maggiore G, Schmitz J, Hadchouel M, Bernard O. A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/ isomerase deficiency. J Pediatr 1994; 125: 379-384
102. Cheng JB, Jacquemin E, Gerhardt M, Nazer H, Cresteil D, Heubi JE, Setchell KD, Russell DW. Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. J Clin Endocrinol Metab 2003; 88: 1833-1841
103. Setchell KD, Suchy FJ, Welsh MB, Zimmer-Nechemias L, Heubi J, Balistreri WF. Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. J Clin Invest 1988; 82: 2148-2157
104. Ferdinandusse S, Houten SM. Peroxisomes and bile acid biosynthesis. Biochim Biophys Acta 2006; 1763: 1427-1440
105. Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 1991; 266: 7779-7783
106. Shimazu K, Kuwabara M, Yoshii M, Kihira K, Takeuchi H, Nakano I, Ozawa S, Onuki M, Hatta Y, Hoshita T. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis. J Biochem 1986; 99: 477-483
107. Batta AK, Salen G, Shefer S, Tint GS, Batta M. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid. J Lipid Res 1987; 28: 1006-1012 112 Clayton PT, Casteels M, Mieli-Vergani G, Lawson AM. Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols: a new inborn error of bile acid synthesis? Pediatr Res 1995; 37: 424-431
108. Ferdinandusse S, Denis S, Clayton PT, Graham A, Rees JE, Allen JT, McLean BN, Brown AY, Vreken P, Waterham HR, Wanders RJ. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet 2000; 24: 188-191
109. Setchell KD, Heubi JE, Bove KE, O'Connell NC, Brewsaugh T, Steinberg SJ, Moser A, Squires RH Jr. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology 2003; 124: 217-232
110. Wanders RJ. Metabolic and molecular basis of peroxisomal disorders: a review. Am J Med Genet A 2004; 126A: 355-375
111. Van Eldere JR, Parmentier GG, Eyssen HJ, Wanders RJ, Schutgens RB, Vamecq J, Van Hoof F, Poll-The BT, Saudubray JM. Bile acids in peroxisomal disorders. Eur J Clin Invest 1987; 17: 386-390
112. Monnens L, Bakkeren J, Parmentier G, Janssen G, van Haelst U, Trijbels F, Eyssen H. Disturbances in bile acid metabolism of infants with the Zellweger (cerebro-hepatorenal) syndrome. Eur J Pediatr 1980; 133: 31-35
113. Kase BF, Pedersen JI, Strandvik B, Björkhem I. In vivo and vitro studies on formation of bile acids in patients with Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic and chenodeoxycholic acid. J Clin Invest 1985; 76: 2393-2402
114. Setchell KD, Heubi JE, O'Connell C, Hofmann A, Lavine J. Identification of a unique inborn error in bile acid conjugation involving a deficiency in amidation. In: Paumgartner G, Strehl A, Gerok W. Bile Acids in Hepatobiliary Diseases: Basic Research and Clinical Application. Boston: Kluwer Academic, 1997
115. Hubbard B, Doege H, Punreddy S, Wu H, Huang X, Kaushik VK, Mozell RL, Byrnes JJ, Stricker-Krongrad A, Chou CJ, Tartaglia LA, Lodish HF, Stahl A, Gimeno RE. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity. Gastroenterology 2006; 130: 1259-1269
116. Carlton VE, Harris BZ, Puffenberger EG, Batta AK, Knisely AS, Robinson DL, Strauss KA, Shneider BL, Lim WA, Salen G, Morton DH, Bull LN. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet 2003; 34: 91-96
117. Jansen PL, Sturm E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int 2003; 23: 315-322
118. Kubitz R, Keitel V, Häussinger D. Inborn errors of biliary canalicular transport systems. Methods Enzymol 2005; 400: 558-569
119. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Németh A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, Thompson RJ. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-238
120. Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, Koning JH, De Jager-Krikken A, Kuipers F, Stellaard F, Bijleveld CM, Gouw A, Van Goor H, Thompson RJ, Müller M. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999; 117: 1370-1379
121. van Mil SW, van der Woerd WL, van der Brugge G, Sturm E, Jansen PL, Bull LN, van den Berg IE, Berger R, Houwen RH, Klomp LW. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004; 127: 379-384
122. Eloranta ML, Häkli T, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand J Gastroenterol 2003; 38: 648-652
123. Keitel V, Vogt C, Häussinger D, Kubitz R. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 2006; 131: 624-629
124. Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses 1986; 19: 57-69
125. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, Bernard O, Hadchouel M. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904-908
126. Sokol RJ, Devereaux M, Khandwala R, O'Brien K. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology 1993; 17: 869-881
127. Perez MJ, Macias RI, Duran C, Monte MJ, Gonzalez-Buitrago JM, Marin JJ. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid. J Hepatol 2005; 43: 324-332
128. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103: 137-145
129. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998; 4: 165-178
130. Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001; 33: 616-626
131. Marin JJ, Barbero ER, Herrera MC, Tabernero A, Monte MJ. Bile acid-induced modifications in DNA synthesis by the regenerating perfused rat liver. Hepatology 1993; 18: 1182-1192
132. Monte JM, Barbero ER, Villanueva GR, Serrano MA, Marin JJ. Role of rate-limiting enzymes of nucleotide metabolism in taurocholate-induced DNA synthesis inhibition. J Hepatol 1996; 25: 191-199
133. Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006; 312: 233-236
134. Zimber A, Zusman I, Bentor R, Pinus H. Effects of lithocholic acid exposure throughout pregnancy on late prenatal and early postnatal development in rats. Teratology 1991; 43: 355-361
135. Debruyne PR, Bruyneel EA, Li X, Zimber A, Gespach C, Mareel MM. The role of bile acids in carcinogenesis. Mutat Res 2001; 480-481: 359-369
136. Costarelli V, Sanders TA. Plasma deoxycholic acid concentration is elevated in postmenopausal women with newly diagnosed breast cancer. Eur J Clin Nutr 2002; 56: 925-927
137. Raju U, Levitz M, Javitt NB. Bile acids in human breast cyst fluid: the identification of lithocholic acid. J Clin Endocrinol Metab 1990; 70: 1030-1034
138. Kim I, Morimura K, Shah Y, Yang Q, Ward JM, Gonzalez FJ. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 2007; 28: 940-946
139. Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res 2007; 67: 863-867
140. Weber AM, Roy CC. Bile acid metabolism in children with cystic fibrosis. Acta Paediatr Scand Suppl 1985; 317: 9-15
141. Watkins JB 3rd, Sanders RA. Diabetes mellitus-induced alterations of hepatobiliary function. Pharmacol Rev 1995; 47: 1-23
142. Gaillard P, Carrupt PA, Testa B, Boudon A. Molecular lipophilicity potential, a tool in 3D QSAR: method and applications. J Comput Aided Mol Des 1994; 8: 83-96
143. Small DM. The formation of gallstones. Adv Intern Med 1970; 16: 243-264